Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

‘Supplement’ On CBD Product Label A Bullseye For US Litigants, Says Attorney

Dec 13 2019

• By Eileen Francis

Related Content

FDA's Initial IND Warnings For CBD Supplements Could Ignite Regulatory Test

Feb 16 2016

FDA Warns 15 CBD Product Marketers For Violations, Cautions Consumers: CBD May Harm You

Nov 27 2019

CBD Products For Children Could Connect The Dots To FDA's Problem For Congress

Oct 22 2019

CBD Suits Challenge ‘THC-Free’ Claims After Users Fail Drug Tests; Plaintiffs Bar May Just Be Warming Up

Aug 22 2019

Additional Topics

International United States US States Dietary Supplements FDA Regulation Enforcement Advertising, Marketing & Sales Business Strategies Commercial Companies Compliance Ingredients Legal Issues Policy Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window